The University of Szeged is a public research university in Szeged, Hungary. Established as the Jesuit Academy of Kolozsvár in present-day Cluj-Napoca in 1581, the institution was re-established as a university in 1872 by Emperor Franz Joseph I.

During the past decade, University of Szeged conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 13 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Szeged" #1 sponsor was "Szeged University" with 9 trials, followed by "Aires Pharmaceuticals, Inc." with 2 trials sponsored, "Amicus Therapeutics" with 2 trials sponsored, "Banyan Biomarkers, Inc" with 2 trials sponsored and "Fundación Pública Andaluza Progreso y Salud" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Szeged" #1 collaborator was "Szeged University" with 5 trials as a collaborator, "Karolinska Institutet" with 3 trials as a collaborator, "Andaluz Health Service" with 2 trials as a collaborator, "Atrys Health" with 2 trials as a collaborator and "August Pi Sunyer Biomedical Research Institute" with 2 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "University of Szeged" are "Low Back Pain" (3 trials), "Acromegaly" (2 trials), "Breast Cancer" (2 trials), "Coronary Artery Disease" (2 trials) and "Hypoparathyroidism" (2 trials). Many other conditions were trialed in "University of Szeged" in a lesser frequency.

Most popular intervention types in "University of Szeged" are "Drug" (32 trials), "Other" (12 trials), "Device" (8 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "AT2221" (2 trials), "ATB200" (2 trials), "NPSP558" (2 trials) and "ACP-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Szeged" are 52 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 16 active trials in "University of Szeged". 1 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in University of Szeged, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Szeged, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".